| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9272581 | Revue du Rhumatisme | 2005 | 6 Pages |
Abstract
Conclusion. - Older age and high-dose glucocorticoid therapy are associated with an increased risk of severe pyogenic infection during infliximab therapy. Caution is in order when starting and monitoring infliximab therapy in patients with risk factors. Our data also emphasize the need for a careful search for risk factors before each infliximab infusion.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Immunology, Allergology and Rheumatology
Authors
Hélène Maillard, Paul Ornetti, Laurent Grimault, Jean-François Ramon, Sylvie Melac Ducamp, Tahar Saidani, Christian Tavernier, Jean Francis Maillefert,